Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Type 2 Medications Articles

Drug Combo Slows Onset of Type 2 Diabetes
Vitamin D May Reduce Risk for Type 2
Tradjenta, a Drug for Type 2s, Now on U.S. Market
Looking at Cannabis Based Type 2 Treatment
Type 2 Profile: Tony Flores
Keeping the Weight Off: An Interview with Ellen Granberg, PhD
A New Kind of Pharmacist
Need Medicine and Have No Insurance for Your Diabetes?
Flushing Away High Blood Sugar
Walgreens in South Florida and Diabetes Research Institute Foundation Announce Unique Partnership
Diabetes Health Reference Charts
Type 2 Medications (PDF)
Type 2 Meds Reference Guide (PDF)
See All Charts…
Type 2 Medications Archives
Browse the Type 2 Medications Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

ACE Inhibitor Does Not Stop Progression to Diabetes


Feb 1, 2007

“Among persons with impaired fasting glucose levels or impaired glucose tolerance, the use of ramipril [Altace] for three years does not significantly reduce the incidence of diabetes or death.”

Altace, an ACE inhibitor, was studied in a double-blind randomized clinical trial.

“We randomly assigned 5,269 participants without cardiovascular disease but with impaired fasting glucose levels or impaired glucose tolerance to receive Altace (up to 15 mg per day) or placebo (and Avandia or placebo) and followed them for a median of three years,” write the researchers.

At the end of the study, the average fasting plasma glucose level was not significantly lower in the Altace group (102.7 mg/dl) than in the placebo group (103.4 mg/dl), though plasma glucose levels two hours after a meal were lower in the Altace group (135.1 mg/dl vs. 140.5 mg/dl respectively).

* * *

Source: The New England Journal of Medicine, October 12, 2006

Categories: Diabetes, Diabetes, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Feb 1, 2007

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.